Sarissa Capital Management LP 13D/13G Filings for Iterum Therapeutics plc (ITRM)

Sarissa Capital Management LP 13D and 13G filings for Iterum Therapeutics plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-12
5:01 pm
Sale
2021-02-11 13D Iterum Therapeutics plc
ITRM
Sarissa Capital Management LP 0
0.000%
-1,286,185decrease
(Position Closed)
Filing
2020-11-23
5:02 pm
Purchase
2020-11-22 13D Iterum Therapeutics plc
ITRM
Sarissa Capital Management LP 1,286,185
30.950%
1,286,185increase
(New Position)
Filing